These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2664047)

  • 1. Controlled clinical trial for evaluation of antimicrobial drug activity against M. leprae.
    Grosset JH; Ji BH
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):529-31. PubMed ID: 2664047
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
    Dhople AM; Dimova V
    Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA; Gardner GD
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phenolic glycolipid-I synthesis in extracellular Mycobacterium leprae as an indicator of antimicrobial activity.
    Harris EB; Franzblau SG; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):588-91. PubMed ID: 3065422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of selected beta-lactam antibiotics against Mycobacterium leprae.
    Shepard CC; Van Landingham RM; Walker LL; Good RC
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):322-7. PubMed ID: 3298478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of enhancing effect of trimethoprim on the activity of a sulfonamide against Mycobacterium leprae.
    Pattyn SR; Verdoolaege-Van Loo G
    Int J Lepr Other Mycobact Dis; 1972; 40(3):320. PubMed ID: 4574275
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity against M. leprae of lincomycin and two derivatives, of amicetin, phosphonomycin and two derivatives of tetrahydronaphthylaminopropylpiperidine.
    Shepard CC; Van Landingham RM; Redus MA; Walker LL
    Int J Lepr Other Mycobact Dis; 1971; 39(3):742-4. PubMed ID: 4948222
    [No Abstract]   [Full Text] [Related]  

  • 8. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol (1962); 1969; 7():211-51. PubMed ID: 4190238
    [No Abstract]   [Full Text] [Related]  

  • 9. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antibacterial drugs on the ultrastructure of Mycobacterium leprae in human skin.
    Edwards RP; Draper GJ; Draper P
    Lepr Rev; 1972 Dec; 43(4):173-80. PubMed ID: 4579978
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of rodent models in assessing antimicrobial activity against Mycobacterium leprae.
    Gelber RH
    Lepr Rev; 1986; 57 Suppl 3():137-48. PubMed ID: 3553807
    [No Abstract]   [Full Text] [Related]  

  • 12. Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1969; 37(4):389-97. PubMed ID: 4918202
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of the mouse foot-pad technique in immunologically normal mice in support of clinical drug trials, and a review of earlier clinical drug trials in lepromatous leprosy.
    Levy L
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):823-9. PubMed ID: 3325574
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo activities of novel benzoxazinorifamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA
    Indian J Lepr; 1995; 67(4):375-82. PubMed ID: 8849914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the bactericidal activity of a series of rifampicins against Mycobacterium leprae.
    Pattyn SR
    Arzneimittelforschung; 1982; 32(1):15-7. PubMed ID: 7037013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
    Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of ofloxacin against Mycobacterium leprae in the mouse.
    Grosset JH; Guelpa-Lauras CC; Perani EG; Beoletto C
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):259-64. PubMed ID: 3045223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of ansamycin against Mycobacterium leprae in mice.
    Hastings RC; Jacobson RR
    Lancet; 1983 Nov; 2(8358):1079-80. PubMed ID: 6138619
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacterial growth kinetics of "M. lufu" in the presence and absence of various drugs alone and in combination. A model for the development of combined chemotherapy against M. leprae?
    Seydel JK; Wempe EG
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):20-30. PubMed ID: 7042611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.